Douglas W Ball Selected Research

Douglas W Ball Research Topics

Disease

18	Neoplasms (Cancer) 02/2022 - 05/2002
13	Thyroid Neoplasms (Thyroid Cancer) 02/2022 - 09/2003
6	medullary Thyroid cancer 01/2024 - 01/2006
3	Hypertension (High Blood Pressure) 01/2019 - 06/2015
3	Anaplastic Thyroid Carcinoma 09/2015 - 12/2007
2	Fatigue 01/2019 - 01/2016
2	Diarrhea 01/2019 - 01/2016
2	Disease Progression 01/2016 - 08/2015
2	Carcinoid Tumor (Carcinoid) 01/2012 - 07/2005
2	Neoplasm Metastasis (Metastasis) 06/2010 - 08/2006
2	Pancreatic Neoplasms (Pancreatic Cancer) 06/2010 - 06/2003
1	Neuroendocrine Carcinoma 01/2024
1	Hodgkin Disease (Hodgkin's Disease) 01/2024
1	Thrombotic Microangiopathies 02/2022
1	Hepatocellular Carcinoma (Hepatoma) 02/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2022
1	Proteinuria 02/2022
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 01/2019
1	Deglutition Disorders (Dysphagia) 01/2016
1	Carcinoma (Carcinomatosis) 09/2015
1	Sarcoma (Soft Tissue Sarcoma) 08/2015
1	Hypertensive Crisis 06/2015
1	Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma) 06/2015
1	Small Cell Carcinoma 01/2012
1	Lung Neoplasms (Lung Cancer) 01/2012
1	Mucositis 07/2011
1	Hyperplasia 05/2011
1	Graves Disease (Basedow Disease) 05/2011
1	Goiter 05/2011
1	Thyroid Nodule (Nodule, Thyroid) 05/2011
1	Medullary Carcinoma 05/2011
1	Papillary Thyroid Cancer 12/2007
1	Acromegaly 01/2007
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2007

Drug/Important Bio-Agent (IBA)

6	Tyrosine Kinase InhibitorsIBA 02/2022 - 01/2006
5	Phosphotransferases (Kinase)IBA 02/2022 - 06/2010
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 12/2007
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2019 - 10/2011
3	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2024 - 01/2007
3	lenvatinibIBA 02/2022 - 08/2015
3	cabozantinibIBA 01/2019 - 07/2011
3	Proteins (Proteins, Gene)FDA Link 02/2013 - 05/2002
3	Messenger RNA (mRNA)IBA 01/2012 - 05/2002
2	pazopanib FDA Link 01/2019 - 11/2015
2	trametinibIBA 01/2019 - 11/2015
2	Angiopoietin-2IBA 01/2016 - 08/2015
2	Sorafenib (BAY 43-9006)FDA Link 11/2015 - 12/2014
2	Transcription Factors (Transcription Factor)IBA 06/2015 - 07/2005
2	Cyclin-Dependent Kinase 5IBA 06/2010 - 08/2006
2	AZD 6244IBA 10/2009 - 12/2007
2	CEP 751IBA 01/2006 - 09/2003
2	Basic Helix-Loop-Helix Transcription FactorsIBA 07/2005 - 05/2002
2	Leukemia Inhibitory FactorIBA 02/2005 - 02/2005
1	selpercatinibIBA 01/2024
1	Everolimus FDA Link 02/2022
1	CreatinineIBA 02/2022
1	Parathyroid Hormone (Parathormone)IBA 01/2019
1	Transaminases (Aminotransferases)IBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2016
1	Becaplermin (PDGF-BB)FDA Link 01/2016
1	Interleukin-8 (Interleukin 8)IBA 01/2016
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	tyrosine receptor (receptor, tyrosine)IBA 11/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2015
1	Docetaxel (Taxotere)FDA Link 09/2015
1	Cisplatin (Platino)FDA LinkGeneric 09/2015
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 08/2015
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 08/2015
1	Biomarkers (Surrogate Marker)IBA 08/2015
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 06/2015
1	CatecholaminesIBA 06/2015
1	EnzymesIBA 06/2015
1	vandetanib (ZD6474)IBA 12/2014
1	IodineIBA 12/2014
1	RNA (Ribonucleic Acid)IBA 01/2012
1	Mechanistic Target of Rapamycin Complex 2IBA 10/2011
1	Adenosine Triphosphate (ATP)IBA 10/2011
1	Drug CombinationsIBA 10/2011
1	RAF265IBA 10/2011
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2011
1	Phosphatidylinositols (Phosphatidylinositol)IBA 10/2011
1	Lipase (Acid Lipase)FDA Link 07/2011
1	CalciumIBA 05/2011
1	Pentagastrin (Peptavlon)FDA Link 05/2011
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2010
1	MTOR InhibitorsIBA 10/2009
1	TOR Serine-Threonine KinasesIBA 10/2009
1	Sirolimus (Rapamycin)FDA Link 10/2009
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2009
1	Dihydrotachysterol (AT 10)IBA 12/2007
1	MAP Kinase Kinase 1IBA 12/2007
1	Cytostatic AgentsIBA 12/2007
1	Growth Hormone (Somatotropin)IBA 01/2007

Therapy/Procedure

6	Therapeutics 02/2022 - 09/2007
2	Aftercare (After-Treatment) 12/2007 - 01/2007
1	Drug Therapy (Chemotherapy) 01/2024
1	Drug Tapering 02/2022
1	Thyroidectomy 05/2011